For patients with type 2 diabetes who are taking multiple daily insulin injections, switching to combination treatment with basal insulin plus an agent from one of two newer glucose-lowering drug ...
“Once-weekly IcoSema achieved noninferior A1c reduction and superiority in change in bodyweight, weekly total insulin dose, and hypoglycemia rates vs daily BBT [basal-bolus therapy], suggesting that ...
Please provide your email address to receive an email when new articles are posted on . Adults with diabetes receiving both basal and bolus insulin through a smart pen miss about six doses every 14 ...
ACTON, Mass.--(BUSINESS WIRE)--Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod ® brand of products, today announced ...
(BPT) – Diabetes Alert Day on March 25 is more than just a date on the calendar — it’s a wake-up call for millions of Americans who either live with diabetes or are at risk of developing it. It’s a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results